BACKGROUND: Some strength athletes use androgenic-anabolic steroids (AAS) t
o improve body dimensions, though the drugs' long- and short-term effects h
ave not been definitively established.
OBJECTIVE: This study sought to investigate the short- and long-term effect
s of AAS self-administration on body dimensions and total and regional body
composition.
DESIGN: This prospective, unblinded study involved 35 experienced male stre
ngth athletes: 19 AAS users (drugs were self-administered) and 16 nonuser c
ontrols engaged in their usual training regimens. At baseline, 8 weeks, and
6 weeks after AAS withdrawal (for AAS users) circumferences were measured
at 10 sites, and skinfolds measured at 8 sites. To assess differences in AA
S regimens, 9 subjects took AAS far 8 weeks (short-AAS) and 10 athletes too
k AAS for 12 to 16 weeks (long-AAS). Body composition and anthropometry wer
e assessed at baseline, at the end of AAS use, and 6 weeks later. Lean body
mass (LBM) was calculated from body weight and percentage fat. Total and r
egional body composition was measured by dual-energy x-ray absorptiometry.
RESULTS: AAS use increased users' body weight by 4.4 kg and LBM by 4.5 kg,
and produced increases in several circumferences. Percentage of fat decreas
ed (17.0% to 16.0%), but fat mass remained unchanged. changes persisted 6 w
eeks after drug withdrawal but were not less than those taken at 8 weeks. B
one-free lean mass of all regional body parts increased in subjects taking
AAS, but fat mass was unaffected. Short- and long-term AAS users did not di
ffer in any parameter measured at 8 weeks or after drug withdrawal.
CONCLUSION: In AAS users, 8 weeks of self-administered AAS increased body w
eight, lean body mass, and limb circumferences, but decreased percentage fa
t compared with controls,Changes remained 6 weeks after drug withdrawal, th
ough for some measurements only partially. AAS stimulated the bone-free lea
n mass of all body parts, but it did not affect fat mass. Short-term and lo
ng-term AAS administration produced comparable effects.